Patent ID: 8450339

Claim:
A composition in the form of an aqueous solution comprising: a) ipratropium or a salt thereof in an amount from 0.2 mg to 2 mg per mL, b) xylometazoline or a salt thereof in an amount from 0.4 mg to 5 mg per mL, c) at least one complex binder selected from the group consisting of edetic acid, pentetic acid, nitrilotriacetic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, tartaric acid, malic acid, cortic acid, and salts thereof, d) at least 10% water, and e) 85% glycerol in an amount of 27.0 to 27.9 mg per mL, wherein the solution has a pH in the range from 4.5 to 5.5.